| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |